InnateDB Protein
|
IDBP-60628.7
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
TFAP2A
|
Protein Name
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
Synonyms
|
AP-2; AP-2alpha; AP2TF; BOFS; TFAP2;
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000368928
|
InnateDB Gene
|
IDBG-60624 (TFAP2A)
|
Protein Structure
|
|
Function |
Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter transcription activation. Associates with chromatin to the PITX2 P1 promoter region. {ECO:0000269PubMed:11694877, ECO:0000269PubMed:12586840}.
|
Subcellular Localization |
Nucleus {ECO:0000269PubMed:12586840}.
|
Disease Associations |
Branchiooculofacial syndrome (BOFS) [MIM:113620]: A syndrome characterized by growth retardation, bilateral branchial sinus defects with hemangiomatous, scarred skin, cleft lip with or without cleft palate, pseudocleft of the upper lip, nasolacrimal duct obstruction, low set ears with posterior rotation, a malformed, asymmetrical nose with a broad bridge and flattened tip, conductive or sensorineural deafness, ocular and renal anomalies. {ECO:0000269PubMed:18423521}. Note=The disease is caused by mutations affecting the gene represented in this entry.
|
Tissue Specificity |
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 55 experimentally validated interaction(s) in this database.
They are also associated with 5 interaction(s) predicted by orthology.
Experimentally validated |
Total |
55
[view]
|
Protein-Protein |
45
[view]
|
Protein-DNA |
9
[view]
|
Protein-RNA |
1
[view]
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
Predicted by orthology |
Total |
5 [view]
|
|
|
Molecular Function |
Accession |
GO Term |
GO:0000976
|
transcription regulatory region sequence-specific DNA binding
|
GO:0000978
|
RNA polymerase II core promoter proximal region sequence-specific DNA binding
|
GO:0000979
|
RNA polymerase II core promoter sequence-specific DNA binding
|
GO:0000981
|
sequence-specific DNA binding RNA polymerase II transcription factor activity
|
GO:0000982
|
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity
|
GO:0000987
|
core promoter proximal region sequence-specific DNA binding
|
GO:0001077
|
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription
|
GO:0001078
|
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription
|
GO:0003682
|
chromatin binding
|
GO:0003713
|
transcription coactivator activity
|
GO:0005515
|
protein binding
|
GO:0042803
|
protein homodimerization activity
|
GO:0043565
|
sequence-specific DNA binding
|
GO:0044212
|
transcription regulatory region DNA binding
|
GO:0046983
|
protein dimerization activity
|
|
Biological Process |
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
GO:0001822
|
kidney development
|
GO:0003404
|
optic vesicle morphogenesis
|
GO:0003409
|
optic cup structural organization
|
GO:0006366
|
transcription from RNA polymerase II promoter
|
GO:0007605
|
sensory perception of sound
|
GO:0008285
|
negative regulation of cell proliferation
|
GO:0010628
|
positive regulation of gene expression
|
GO:0010842
|
retina layer formation
|
GO:0010944
|
negative regulation of transcription by competitive promoter binding
|
GO:0021559
|
trigeminal nerve development
|
GO:0021623
|
oculomotor nerve formation
|
GO:0030501
|
positive regulation of bone mineralization
|
GO:0035115
|
embryonic forelimb morphogenesis
|
GO:0042472
|
inner ear morphogenesis
|
GO:0043066
|
negative regulation of apoptotic process
|
GO:0043525
|
positive regulation of neuron apoptotic process
|
GO:0045595
|
regulation of cell differentiation
|
GO:0045892
|
negative regulation of transcription, DNA-templated
|
GO:0045893
|
positive regulation of transcription, DNA-templated
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
GO:0048701
|
embryonic cranial skeleton morphogenesis
|
GO:0060021
|
palate development
|
GO:0060349
|
bone morphogenesis
|
GO:0061029
|
eyelid development in camera-type eye
|
GO:0070172
|
positive regulation of tooth mineralization
|
GO:0071281
|
cellular response to iron ion
|
GO:2000378
|
negative regulation of reactive oxygen species metabolic process
|
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR008121
Transcription factor AP-2 alpha, N-terminal
IPR013854
Transcription factor AP-2, C-terminal
|
PFAM |
PF03299
|
PRINTS |
PR01749
PR01748
|
PIRSF |
|
SMART |
|
TIGRFAMs |
|
Modification |
|
SwissProt |
P05549
|
PhosphoSite |
PhosphoSite-P05549
|
TrEMBL |
|
UniProt Splice Variant |
|
Entrez Gene |
7020
|
UniGene |
Hs.657734
|
RefSeq |
NP_001027451
|
HUGO |
HGNC:11742
|
OMIM |
107580
|
CCDS |
CCDS34337
|
HPRD |
00128
|
IMGT |
|
EMBL |
AL138885
BC017754
CH471087
M36711
M61156
X52611
X77343
|
GenPept |
AAA02487
AAA35539
AAH17754
CAA36842
CAB59735
CAI20064
EAW55249
|
|
|